BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 81557)

  • 1. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.
    Paterson PY; Fujinami RS; Day ED; Varitek VA; Pescovitz MD; Kelly J; Lorand L
    Trans Am Clin Climatol Assoc; 1978; 89():109-18. PubMed ID: 81557
    [No Abstract]   [Full Text] [Related]  

  • 2. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2).
    Paterson PY; Day ED
    Clin Immunol Rev; 1981-1982; 1(4):581-697. PubMed ID: 6188568
    [No Abstract]   [Full Text] [Related]  

  • 3. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM; Alvord EC
    Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
    [No Abstract]   [Full Text] [Related]  

  • 4. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 5. Encephalitogenic epitopes of myelin basic protein.
    Fritz RB; McFarlin DE
    Chem Immunol; 1989; 46():101-25. PubMed ID: 2482036
    [No Abstract]   [Full Text] [Related]  

  • 6. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination.
    Raine CS
    Res Publ Assoc Res Nerv Ment Dis; 1990; 68():37-54. PubMed ID: 1691521
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
    Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental allergic encephalomyelitis: immunological properties of encephalitogenic polypeptides and proteins.
    Lamoureux G; Carnegie PR; McPherson TA; Johnston D
    Clin Exp Immunol; 1967 Sep; 2(5):601-9. PubMed ID: 4965043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats.
    Umehara F; Qin YF; Goto M; Wekerle H; Meyermann R
    Lab Invest; 1990 Feb; 62(2):147-55. PubMed ID: 1689408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
    Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
    J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic aspects of multiple sclerosis and experimental models of inflammatory demyelination.
    Wisniewski HM; Schuller-Levis GB; Mehta PD; Madrid RE; Lassmann H
    Concepts Immunopathol; 1985; 2():128-50. PubMed ID: 2439203
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis.
    Seil FJ; Agrawal HC
    Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
    Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
    Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin basic protein, a specific protein of the central nervous system.
    Karcher D
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():85-7. PubMed ID: 6202352
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS; Wu ZY; Zhang HP; Furtado G; Chen X; Yan SF; Schmidt AM; Brown C; Stern A; LaFaille J; Chess L; Stern DM; Jiang H
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-way cross-reaction between spinal cord protein and myelin basic protein.
    MacPherson CF; Prokopchuk P; Ramshaw IA; Ziola B
    Prog Clin Biol Res; 1984; 146():265-70. PubMed ID: 6201898
    [No Abstract]   [Full Text] [Related]  

  • 19. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis?
    Alvord EC
    Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelin proteolipid protein: an effective autoantigen and target of autoimmunity in multiple sclerosis.
    Greer JM; Pender MP
    J Autoimmun; 2008 Nov; 31(3):281-7. PubMed ID: 18502611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.